Events

ERC Synergy grant information meeting
SEP
Wed
12
11:30 - 13:30

This was 7 years ago

Location

Brussels

Raadzaal / Salle du Conseil



Egmontstraat 5



1000 Brussels

Programmes
ERC

NCP Flanders organises an information meeting on the 2019 call for ERC Synergy grants, in collaboration with the other Belgian National Contact Points at BELSPO and F.R.S.-FNRS.

The information meeting is organised to inform and help support staff and researchers with the preparation of their application for an ERC Synergy grant.

Presentation: http://www.h2020-info-sessions.be/event/erc-synergy-grant-2019-information-meeting/

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.